<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35287794</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2050-084X</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2022</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>eLife</Title><ISOAbbreviation>Elife</ISOAbbreviation></Journal><ArticleTitle>Correlation between leukocyte phenotypes and prognosis of amyotrophic lateral sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e74065</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7554/eLife.74065</ELocationID><Abstract><AbstractText>The prognostic role of immune cells in amyotrophic lateral sclerosis (ALS) remains undetermined. Therefore, we conducted a longitudinal cohort study including 288 ALS patients with up to 5-year follow-up during 2015-2020 recruited at the only tertiary referral center for ALS in Stockholm, Sweden, and measured the levels of differential leukocytes and lymphocyte subpopulations. The primary outcome was risk of death after diagnosis of ALS and the secondary outcomes included functional status and disease progression rate. Cox model was used to evaluate the associations between leukocytes and risk of death. Generalized estimating equation model was used to assess the correlation between leukocytes and functional status and disease progression rate. We found that leukocytes, neutrophils, and monocytes increased gradually over time since diagnosis and were negatively correlated with functional status, but not associated with risk of death or disease progression rate. For lymphocyte subpopulations, NK cells (HR= 0.61, 95% CI = [0.42-0.88] per SD increase) and Th2-diffrentiated CD4<sup>+</sup> central memory T cells (HR= 0.64, 95% CI = [0.48-0.85] per SD increase) were negatively associated with risk of death, while CD4<sup>+</sup> effector memory cells re-expressing CD45RA (EMRA) T cells (HR= 1.39, 95% CI = [1.01-1.92] per SD increase) and CD8<sup>+</sup> T cells (HR= 1.38, 95% CI = [1.03-1.86] per SD increase) were positively associated with risk of death. None of the lymphocyte subpopulations was correlated with functional status or disease progression rate. Our findings suggest a dual role of immune cells in ALS prognosis, where neutrophils and monocytes primarily reflect functional status whereas NK cells and different T lymphocyte populations act as prognostic markers for survival.</AbstractText><CopyrightInformation>&#xa9; 2022, Cui et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Can</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8138-0495</Identifier><AffiliationInfo><Affiliation>Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ingre</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>SLL- ME Neurologi, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xia</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-1922-7152</Identifier><AffiliationInfo><Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersson</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2799-6349</Identifier><AffiliationInfo><Affiliation>Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seitz</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruffin</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-3698-5505</Identifier><AffiliationInfo><Affiliation>Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pawitan</LastName><ForeName>Yudi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piehl</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>SLL- ME Neurologi, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Fang</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3310-6456</Identifier><AffiliationInfo><Affiliation>Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Elife</MedlineTA><NlmUniqueID>101579614</NlmUniqueID><ISSNLinking>2050-084X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007962" MajorTopicYN="N">Leukocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">blood flow</Keyword><Keyword MajorTopicYN="N">human</Keyword><Keyword MajorTopicYN="N">immune cells</Keyword><Keyword MajorTopicYN="N">immunology</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">neuroscience</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword></KeywordList><CoiStatement>CC, CI, LY, XL, JA, CS, NR, YP, FP, FF No competing interests declared</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35287794</ArticleId><ArticleId IdType="pmc">PMC8923665</ArticleId><ArticleId IdType="doi">10.7554/eLife.74065</ArticleId><ArticleId IdType="pii">74065</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FMV. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nature Neuroscience. 2007;10:1538&#x2013;1543. doi: 10.1038/nn2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2014</ArticleId><ArticleId IdType="pubmed">18026097</ArticleId></ArticleIdList></Reference><Reference><Citation>Akinci Ozyurek B, Sahin Ozdemirel T, Buyukyaylaci Ozden S, Erdogan Y, Kaplan B, Kaplan T. Prognostic Value of the Neutrophil to Lymphocyte Ratio (NLR)in Lung Cancer Cases. Asian Pacific Journal of Cancer Prevention. 2017;18:1417&#x2013;1421. doi: 10.22034/APJCP.2017.18.5.1417.</Citation><ArticleIdList><ArticleId IdType="doi">10.22034/APJCP.2017.18.5.1417</ArticleId><ArticleId IdType="pmc">PMC5555556</ArticleId><ArticleId IdType="pubmed">28612596</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, Siklos L, McKercher SR, Appel SH. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. PNAS. 2006;103:16021&#x2013;16026. doi: 10.1073/pnas.0607423103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0607423103</ArticleId><ArticleId IdType="pmc">PMC1613228</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Henkel JS, Zhao W, Wang J, Appel SH. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. PNAS. 2008;105:15558&#x2013;15563. doi: 10.1073/pnas.0807419105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0807419105</ArticleId><ArticleId IdType="pmc">PMC2547419</ArticleId><ArticleId IdType="pubmed">18809917</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Henkel JS, Zhao W, Wang J, Huang A, Wen S, Liao B, Appel SH. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain. 2011;134:1293&#x2013;1314. doi: 10.1093/brain/awr074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr074</ArticleId><ArticleId IdType="pmc">PMC3097891</ArticleId><ArticleId IdType="pubmed">21596768</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen RC, Little NAB, Harmer JR, Ma J, Mirabelli LG, Roller KD, Breivik AM, Signor E, Miller AB, Khong HT. Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis. Oncotarget. 2017;8:32171&#x2013;32189. doi: 10.18632/oncotarget.16291.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.16291</ArticleId><ArticleId IdType="pmc">PMC5458276</ArticleId><ArticleId IdType="pubmed">28418870</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis Amyotrophic lateral sclerosis and other motor neuron disorders: official publication of the World Federation of Neurology. Research Group on Motor Neuron Diseases. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, Siddiqui S, Gabriely G, Lanser AJ, Dake B, Murugaiyan G, Doykan CE, Wu PM, Gali RR, Iyer LK, Lawson R, Berry J, Krichevsky AM, Cudkowicz ME, Weiner HL. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. The Journal of Clinical Investigation. 2012;122:3063&#x2013;3087. doi: 10.1172/JCI62636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI62636</ArticleId><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SJ, Hong YH, Kim SM, Shin JY, Suh YJ, Sung JJ. High neutrophil-to-lymphocyte ratio predicts short survival duration in amyotrophic lateral sclerosis. Scientific Reports. 2020;10:428. doi: 10.1038/s41598-019-57366-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-57366-y</ArticleId><ArticleId IdType="pmc">PMC6965090</ArticleId><ArticleId IdType="pubmed">31949271</ArticleId></ArticleIdList></Reference><Reference><Citation>Coque E, Salsac C, Espinosa-Carrasco G, Varga B, Degauque N, Cadoux M, Crab&#xe9; R, Virenque A, Soulard C, Fierle JK, Brodovitch A, Libralato M, V&#xe9;gh AG, Venteo S, Scamps F, Boucraut J, Laplaud D, Hernandez J, Gergely C, Vincent T, Raoul C. Cytotoxic CD8T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneurons. PNAS. 2019;116:2312&#x2013;2317. doi: 10.1073/pnas.1815961116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1815961116</ArticleId><ArticleId IdType="pmc">PMC6369778</ArticleId><ArticleId IdType="pubmed">30674678</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y, Zhao W, Thonhoff JR, Wang J, Wen S, Appel SH. Increased activation ability of monocytes from ALS patients. Experimental Neurology. 2020;328:113259. doi: 10.1016/j.expneurol.2020.113259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2020.113259</ArticleId><ArticleId IdType="pubmed">32105709</ArticleId></ArticleIdList></Reference><Reference><Citation>Garofalo S, Cocozza G, Porzia A, Inghilleri M, Raspa M, Scavizzi F, Aronica E, Bernardini G, Peng L, Ransohoff RM, Santoni A, Limatola C. Natural killer cells modulate motor neuron-immune cell cross talk in models of Amyotrophic Lateral Sclerosis. Nature Communications. 2020;11:1773. doi: 10.1038/s41467-020-15644-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15644-8</ArticleId><ArticleId IdType="pmc">PMC7156729</ArticleId><ArticleId IdType="pubmed">32286313</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendelman HE, Appel SH. Neuroprotective activities of regulatory T cells. Trends in Molecular Medicine. 2011;17:687&#x2013;688. doi: 10.1016/j.molmed.2011.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2011.08.005</ArticleId><ArticleId IdType="pmc">PMC5892451</ArticleId><ArticleId IdType="pubmed">21996344</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammarberg H, Lidman O, Lundberg C, Eltayeb SY, Gielen AW, Muhallab S, Svenningsson A, Lind&#xe5; H, van Der Meide PH, Cullheim S, Olsson T, Piehl F. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. The Journal of Neuroscience. 2000;20:5283&#x2013;5291. doi: 10.1523/JNEUROSCI.20-14-05283.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-14-05283.2000</ArticleId><ArticleId IdType="pmc">PMC6772346</ArticleId><ArticleId IdType="pubmed">10884312</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, Beers DR, Wen S, Rivera AL, Toennis KM, Appel JE, Zhao W, Moore DH, Powell SZ, Appel SH. Regulatory T&#x2010;lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Molecular Medicine. 2012;5:64&#x2013;79. doi: 10.1002/emmm.201201544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201201544</ArticleId><ArticleId IdType="pmc">PMC3569654</ArticleId><ArticleId IdType="pubmed">23143995</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D, Shi FD, Jung S, Pien GC, Wang J, Salazar-Mather TP, He TT, Weaver JT, Ljunggren HG, Biron CA, Littman DR, Ransohoff RM. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB Journal. 2006;20:896&#x2013;905. doi: 10.1096/fj.05-5465com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.05-5465com</ArticleId><ArticleId IdType="pubmed">16675847</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M, G&#xfc;nther R, Akg&#xfc;n K, Hermann A, Ziemssen T. Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis. Scientific Reports. 2020;10:e8. doi: 10.1038/s41598-020-62756-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62756-8</ArticleId><ArticleId IdType="pmc">PMC7125229</ArticleId><ArticleId IdType="pubmed">32246039</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones KJ, Lovett-Racke AE, Walker CL, Sanders VM. CD4 + T Cells and Neuroprotection: Relevance to Motoneuron Injury and Disease. Journal of Neuroimmune Pharmacology. 2015;10:587&#x2013;594. doi: 10.1007/s11481-015-9625-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-015-9625-x</ArticleId><ArticleId IdType="pmc">PMC5100893</ArticleId><ArticleId IdType="pubmed">26148561</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Eliot M, Koestler DC, Wu WC, Kelsey KT. Association of Neutrophil-to-Lymphocyte Ratio With Mortality and Cardiovascular Disease in the Jackson Heart Study and Modification by the Duffy Antigen Variant. JAMA Cardiology. 2018;3:455&#x2013;462. doi: 10.1001/jamacardio.2018.1042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2018.1042</ArticleId><ArticleId IdType="pmc">PMC6128503</ArticleId><ArticleId IdType="pubmed">29801037</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nature Reviews. Immunology. 2016;16:626&#x2013;638. doi: 10.1038/nri.2016.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Komine O, Yamanaka K. Neuroinflammation in motor neuron disease. Nagoya Journal of Medical Science. 2015;77:537&#x2013;549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4664586</ArticleId><ArticleId IdType="pubmed">26663933</ArticleId></ArticleIdList></Reference><Reference><Citation>Labra J, Menon P, Byth K, Morrison S, Vucic S. Rate of disease progression: a prognostic biomarker in ALS. Journal of Neurology, Neurosurgery, and Psychiatry. 2016;87:628&#x2013;632. doi: 10.1136/jnnp-2015-310998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310998</ArticleId><ArticleId IdType="pubmed">26152368</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai JD, Ichida JK. C9ORF72 protein function and immune dysregulation in amyotrophic lateral sclerosis. Neuroscience Letters. 2019;713:134523. doi: 10.1016/j.neulet.2019.134523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.134523</ArticleId><ArticleId IdType="pubmed">31568865</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Cheng X, Zhong S, Zhang X, Liu C, Liu F, Zhao C. Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis. Frontiers in Neuroscience. 2020;14:575. doi: 10.3389/fnins.2020.00575.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00575</ArticleId><ArticleId IdType="pmc">PMC7308438</ArticleId><ArticleId IdType="pubmed">32612503</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Regod&#xf3;n Wallin A, Samuelsson K, Press R, Zachau A, Ronnevi L-O, Kierkegaard M, Andersen PM, Hillert J, Fang F, Ingre C. The Swedish motor neuron disease quality registry. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2018;19:528&#x2013;537. doi: 10.1080/21678421.2018.1497065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1497065</ArticleId><ArticleId IdType="pubmed">30296856</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, Shefner J, WFN Research Group On ALS/MND A revision of the El Escorial criteria - 2015. Amyotrophic Lateral Sclerosis &amp; Frontotemporal Degeneration. 2015;16:291&#x2013;292. doi: 10.3109/21678421.2015.1049183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Maecker HT, McCoy JP, Nussenblatt R. Standardizing immunophenotyping for the Human Immunology Project. Nature Reviews. Immunology. 2012;12:191&#x2013;200. doi: 10.1038/nri3158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3158</ArticleId><ArticleId IdType="pmc">PMC3409649</ArticleId><ArticleId IdType="pubmed">22343568</ArticleId></ArticleIdList></Reference><Reference><Citation>Makary MM, Weerasekara A, Rodham H, Hightower BG, Tseng C-EJ, Chan J, Chew S, Paganoni S, Ratai E-M, Z&#xfc;rcher NR, Hooker JM, Atassi N, Babu S. Comparison of Two Clinical Upper Motor Neuron Burden Rating Scales in ALS Using Quantitative Brain Imaging. ACS Chemical Neuroscience. 2021;12:906&#x2013;916. doi: 10.1021/acschemneuro.0c00772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00772</ArticleId><ArticleId IdType="pubmed">33576234</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Muriana A, Mancuso R, Francos-Quijorna I, Olmos-Alonso A, Osta R, Perry VH, Navarro X, Gomez-Nicola D, L&#xf3;pez-Vales R. CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves. Scientific Reports. 2016;6:25663. doi: 10.1038/srep25663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep25663</ArticleId><ArticleId IdType="pmc">PMC4865981</ArticleId><ArticleId IdType="pubmed">27174644</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley ME, O&#x2019;Rourke JG, Y&#xe1;&#xf1;ez A, Markman JL, Ho R, Wang X, Chen S, Lall D, Jin M, Muhammad AKMG, Bell S, Landeros J, Valencia V, Harms M, Arditi M, Jefferies C, Baloh RH. C9orf72 in myeloid cells suppresses STING-induced inflammation. Nature. 2020;585:96&#x2013;101. doi: 10.1038/s41586-020-2625-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2625-x</ArticleId><ArticleId IdType="pmc">PMC7484469</ArticleId><ArticleId IdType="pubmed">32814898</ArticleId></ArticleIdList></Reference><Reference><Citation>McGill RB, Steyn FJ, Ngo ST, Thorpe KA, Heggie S, Ruitenberg MJ, Henderson RD, McCombe PA, Woodruff TM. Monocytes and neutrophils are associated with clinical features in amyotrophic lateral sclerosis. Brain Communications. 2020;2:fcaa013. doi: 10.1093/braincomms/fcaa013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa013</ArticleId><ArticleId IdType="pmc">PMC7530830</ArticleId><ArticleId IdType="pubmed">33033799</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Bender DE, Segal BM, Feldman EL. The dual roles of immunity in ALS: injury overrides protection. Neurobiology of Disease. 2015;77:1&#x2013;12. doi: 10.1016/j.nbd.2015.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.02.017</ArticleId><ArticleId IdType="pubmed">25726748</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Zhou T, Kashlan SR, Little RJ, Goutman SA, Feldman EL. Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression. JAMA Neurology. 2017;74:1446&#x2013;1454. doi: 10.1001/jamaneurol.2017.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.2255</ArticleId><ArticleId IdType="pmc">PMC5822195</ArticleId><ArticleId IdType="pubmed">28973548</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Famie JP, Piecuch CE, Raue KD, Mendelson FE, Pieroni CH, Iniguez SD, Zhao L, Goutman SA, Feldman EL. NK cells associate with ALS in a sex- and age-dependent manner. JCI Insight. 2021a;6:147129. doi: 10.1172/jci.insight.147129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.147129</ArticleId><ArticleId IdType="pmc">PMC8262328</ArticleId><ArticleId IdType="pubmed">33974561</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Goutman SA, Boss J, Kim S, Feldman EL. Amyotrophic Lateral Sclerosis Survival Associates With Neutrophils in a Sex-specific Manner. Neurology(R) Neuroimmunology &amp; Neuroinflammation. 2021b;8:e953. doi: 10.1212/NXI.0000000000000953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000953</ArticleId><ArticleId IdType="pmc">PMC8057067</ArticleId><ArticleId IdType="pubmed">33531377</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy AC, Lalor SJ, Lynch MA, Mills KHG. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain, Behavior, and Immunity. 2010;24:641&#x2013;651. doi: 10.1016/j.bbi.2010.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.01.014</ArticleId><ArticleId IdType="pubmed">20138983</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura M, Umehara H, Nakayama T, Yoneda O, Hieshima K, Kakizaki M, Dohmae N, Yoshie O, Imai T. Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. Journal of Immunology (Baltimore, Md. 2002;168:6173&#x2013;6180. doi: 10.4049/jimmunol.168.12.6173.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.168.12.6173</ArticleId><ArticleId IdType="pubmed">12055230</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordin G, M&#xe5;rtensson A, Swolin B, Sandberg S, Christensen NJ, Thorsteinsson V, Franzson L, Kairisto V, Savolainen E-R. A multicentre study of reference intervals for haemoglobin, basic blood cell counts and erythrocyte indices in the adult population of the Nordic countries. Scandinavian Journal of Clinical and Laboratory Investigation. 2004;64:385&#x2013;398. doi: 10.1080/00365510410002797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365510410002797</ArticleId><ArticleId IdType="pubmed">15223702</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawitan Y, Michiels S, Koscielny S, Gusnanto A, Ploner A. False discovery rate, sensitivity and sample size for microarray studies. Bioinformatics (Oxford, England) 2005;21:3017&#x2013;3024. doi: 10.1093/bioinformatics/bti448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bti448</ArticleId><ArticleId IdType="pubmed">15840707</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinilla G, Kumar A, Floaters MK, Pardo CA, Rothstein J, Ilieva H. Increased synthesis of pro-inflammatory cytokines in C9ORF72 patients. Amyotrophic Lateral Sclerosis &amp; Frontotemporal Degeneration. 2021;22:517&#x2013;527. doi: 10.1080/21678421.2021.1912100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1912100</ArticleId><ArticleId IdType="pubmed">33929933</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentzos M, Evangelopoulos E, Sereti E, Zouvelou V, Marmara S, Alexakis T, Evdokimidis I. Alterations of T cell subsets in ALS: a systemic immune activation? Acta Neurologica Scandinavica. 2012;125:260&#x2013;264. doi: 10.1111/j.1600-0404.2011.01528.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2011.01528.x</ArticleId><ArticleId IdType="pubmed">21651502</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolfes L, Schulte-Mecklenbeck A, Schreiber S, Vielhaber S, Herty M, Marten A, Pfeuffer S, Ruck T, Wiendl H, Gross CC, Meuth SG, Boentert M, Pawlitzki M. Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation. Brain Communications. 2021;3:fcab157. doi: 10.1093/braincomms/fcab157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab157</ArticleId><ArticleId IdType="pmc">PMC8363480</ArticleId><ArticleId IdType="pubmed">34405141</ArticleId></ArticleIdList></Reference><Reference><Citation>Segal BM. The role of natural killer cells in curbing neuroinflammation. Journal of Neuroimmunology. 2007;191:2&#x2013;7. doi: 10.1016/j.jneuroim.2007.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2007.09.006</ArticleId><ArticleId IdType="pmc">PMC2215057</ArticleId><ArticleId IdType="pubmed">17904646</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheean RK, McKay FC, Cretney E, Bye CR, Perera ND, Tomas D, Weston RA, Scheller KJ, Djouma E, Menon P, Schibeci SD, Marmash N, Yerbury JJ, Nutt SL, Booth DR, Stewart GJ, Kiernan MC, Vucic S, Turner BJ. Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis. JAMA Neurology. 2018;75:681. doi: 10.1001/jamaneurol.2018.0035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.0035</ArticleId><ArticleId IdType="pmc">PMC5885208</ArticleId><ArticleId IdType="pubmed">29507931</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi FD, Ljunggren HG, La Cava A, Van Kaer L. Organ-specific features of natural killer cells. Nature Reviews. Immunology. 2011;11:658&#x2013;671. doi: 10.1038/nri3065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3065</ArticleId><ArticleId IdType="pmc">PMC3620656</ArticleId><ArticleId IdType="pubmed">21941294</ArticleId></ArticleIdList></Reference><Reference><Citation>Trageser KJ, Smith C, Herman FJ, Ono K, Pasinetti GM. Mechanisms of Immune Activation by c9orf72 Expansions in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Frontiers in Neuroscience. 2019;13:1298. doi: 10.3389/fnins.2019.01298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01298</ArticleId><ArticleId IdType="pmc">PMC6914852</ArticleId><ArticleId IdType="pubmed">31920478</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science (New York, N.Y.) 2011;331:44&#x2013;49. doi: 10.1126/science.1198687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1198687</ArticleId><ArticleId IdType="pmc">PMC3089969</ArticleId><ArticleId IdType="pubmed">21212348</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q-Q, Hou Y-B, Zhang L-Y, Ou R-W, Cao B, Chen Y-P, Shang H-F. Neutrophil-to-lymphocyte ratio in sporadic amyotrophic lateral sclerosis. Neural Regeneration Research. 2022;17:875&#x2013;880. doi: 10.4103/1673-5374.322476.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.322476</ArticleId><ArticleId IdType="pmc">PMC8530123</ArticleId><ArticleId IdType="pubmed">34472488</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf D, Bangs DJ, Sidney J, Kolla RV, De Silva AD, de Silva AM, Crotty S, Peters B, Sette A. Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity. PNAS. 2015;112:E4256&#x2013;E4263. doi: 10.1073/pnas.1505956112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1505956112</ArticleId><ArticleId IdType="pmc">PMC4534238</ArticleId><ArticleId IdType="pubmed">26195744</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamudio F, Loon AR, Smeltzer S, Benyamine K, Navalpur Shanmugam NK, Stewart NJF, Lee DC, Nash K, Selenica M-LB. TDP-43 mediated blood-brain barrier permeability and leukocyte infiltration promote neurodegeneration in a low-grade systemic inflammation mouse model. Journal of Neuroinflammation. 2020;17:283. doi: 10.1186/s12974-020-01952-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01952-9</ArticleId><ArticleId IdType="pmc">PMC7519496</ArticleId><ArticleId IdType="pubmed">32979923</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A. A comprehensive review of amyotrophic lateral sclerosis. Surgical Neurology International. 2015;6:171. doi: 10.4103/2152-7806.169561.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId><ArticleId IdType="pmc">PMC4653353</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId></ArticleIdList></Reference><Reference><Citation>Zondler L, M&#xfc;ller K, Khalaji S, Bliederh&#xe4;user C, Ruf WP, Grozdanov V, Thiemann M, Fundel-Clemes K, Freischmidt A, Holzmann K, Strobel B, Weydt P, Witting A, Thal DR, Helferich AM, Hengerer B, Gottschalk K-E, Hill O, Kluge M, Ludolph AC, Danzer KM, Weishaupt JH. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathologica. 2016;132:391&#x2013;411. doi: 10.1007/s00401-016-1548-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1548-y</ArticleId><ArticleId IdType="pubmed">26910103</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>